Accumulated evidences indicate that the COX-2 pathway has been implicated in liver inflammation, matrix remodelling, fibrosis progress and development of hepatocellular carcinoma [82, 83]. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.